• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两例犬用oclacitinib 治疗角化过度性多形红斑的快速应答。

Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs.

机构信息

Department of Clinical Sciences, College of Veterinary Medicine, NC State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA.

Department of Population Health and Pathobiology, College of Veterinary Medicine, NC State University, 1060 William Moore Drive, Raleigh, NC, 27607, USA.

出版信息

Vet Dermatol. 2020 Aug;31(4):330-e86. doi: 10.1111/vde.12852. Epub 2020 Apr 19.

DOI:10.1111/vde.12852
PMID:32307815
Abstract

BACKGROUND

Hyperkeratotic erythema multiforme (HKEM) is a clinically distinct dermatosis and poorly characterized syndrome, comprised of hyperkeratotic plaques with variable symmetry and apoptosis similar to "classic" erosive canine EM. Hyperkeratotic EM has a protracted clinical course and, although treatments with glucocorticoids, azathioprine and/or ciclosporin have been tried, rates of remission are low.

OBJECTIVES

To describe successful treatment of HKEM in two dogs using oclacitinib.

ANIMALS

A 7-year-old, spayed Havanese dog (Case 1) and a 1-year-old, intact cryptorchid Dachshund dog (Case 2).

METHODS

Case characterization and clinical diagnoses were based on lesion character, surgical biopsy, cytological evaluation, culture, direct immunofluorescence (DIF) and expected responses to treatments.

RESULTS

Both cases exhibited multifocal, often symmetrical hyperkeratotic plaques with adherent scale. Histological findings revealed prominent epidermal hyperplasia, parakeratotic hyperkeratosis, lymphocytic dermatitis and transepidermal apoptosis with lymphocytic satellitosis. DIF revealed fine, patchy IgG, IgM and IgA basement membrane deposits (Case 2). Both dogs exhibited rapid improvement with oral oclacitinib (0.6-0.9 mg/kg twice daily) with a complete remission of clinical signs observed in 12 and seven weeks in cases 1 and 2, respectively.

CONCLUSION AND CLINICAL IMPORTANCE

Oclacitinib could be considered as a fast-acting and effective treatment option for HKEM in dogs.

摘要

背景

角化过度性多形红斑(HKEM)是一种具有独特临床特征的皮肤病,也是一种特征不明显的综合征,其特征为角化过度斑块,具有不同的对称性和类似“经典”糜烂性犬多形红斑的凋亡。角化过度性 EM 具有较长的临床病程,尽管尝试了糖皮质激素、硫唑嘌呤和/或环孢素治疗,但缓解率较低。

目的

描述使用oclacitinib 成功治疗两只犬的 HKEM。

动物

一只 7 岁、绝育的哈瓦那犬(病例 1)和一只 1 岁、未去势的短毛腊肠犬(病例 2)。

方法

基于病变特征、手术活检、细胞学评估、培养、直接免疫荧光(DIF)和预期的治疗反应对病例进行特征描述和临床诊断。

结果

两例均表现为多灶性、常对称的角化过度斑块,伴有黏附性鳞屑。组织学发现显示明显的表皮增生、角化不全性角化过度、淋巴细胞性皮炎和伴有淋巴细胞卫星现象的表皮凋亡。DIF 显示细斑状 IgG、IgM 和 IgA 基底膜沉积(病例 2)。两例犬均口服 oclacitinib(0.6-0.9mg/kg,每日两次)后迅速改善,病例 1 和 2 的临床症状分别在 12 周和 7 周完全缓解。

结论和临床意义

oclacitinib 可被视为犬 HKEM 的一种快速起效且有效的治疗选择。

相似文献

1
Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs.两例犬用oclacitinib 治疗角化过度性多形红斑的快速应答。
Vet Dermatol. 2020 Aug;31(4):330-e86. doi: 10.1111/vde.12852. Epub 2020 Apr 19.
2
Hyperkeratotic erythema multiforme variant in 17 dogs.17只犬的角化过度型多形红斑变异型
Vet Dermatol. 2023 Apr;34(2):125-133. doi: 10.1111/vde.13141. Epub 2022 Dec 12.
3
The role of oclacitinib in the management of ischaemic dermatopathy in four dogs.奥克拉替尼在四只犬缺血性皮肤病治疗中的作用。
Vet Dermatol. 2019 Jun;30(3):201-e63. doi: 10.1111/vde.12743. Epub 2019 Apr 21.
4
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.一项比较奥克拉替尼和环孢素在控制宠物狗特应性皮炎方面的疗效和安全性的双盲、随机临床试验。
Vet Dermatol. 2015 Feb;26(1):23-30, e7-8. doi: 10.1111/vde.12186. Epub 2014 Dec 12.
5
Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.在澳大利亚,比较奥克拉替尼(爱波克®)与泼尼松龙对控制宠物犬过敏性皮炎相关瘙痒及临床症状的疗效。
Vet Dermatol. 2014 Dec;25(6):512-8, e86. doi: 10.1111/vde.12166. Epub 2014 Aug 11.
6
A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.奥克拉替尼对特应性比格犬群体表皮致敏和经皮水分流失影响的一项初步研究。
Vet Dermatol. 2018 Oct;29(5):439-e146. doi: 10.1111/vde.12660. Epub 2018 Jun 21.
7
The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study.用奥克拉替尼治疗的过敏性皮炎犬的尿路感染和亚临床菌尿症发生率:一项前瞻性研究。
Vet Dermatol. 2017 Oct;28(5):485-e113. doi: 10.1111/vde.12450. Epub 2017 May 17.
8
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.一项关于Janus激酶抑制剂奥克拉替尼(Apoquel®)在患有特应性皮炎的宠物犬中的疗效和安全性的双盲、随机、安慰剂对照试验。
Vet Dermatol. 2013 Dec;24(6):587-97, e141-2. doi: 10.1111/vde.12088.
9
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.奥克拉替尼在患有特应性和过敏性皮肤病的犬类中的长期同情用药:安全性、有效性和生活质量
Vet Dermatol. 2015 Jun;26(3):171-9, e35. doi: 10.1111/vde.12194. Epub 2015 Feb 16.
10
Successful Treatment With Prednisolone and Mycophenolate Mofetil in a Dog With Recurrent Erythema Multiforme Minor.泼尼松龙和霉酚酸酯治疗犬复发性小形多形红斑的疗效观察
Top Companion Anim Med. 2023 Jan-Feb;52:100755. doi: 10.1016/j.tcam.2022.100755. Epub 2022 Dec 28.

引用本文的文献

1
Erythema multiforme, Steven Johnson syndrome, and toxic epidermal necrolysis.多形红斑、史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症。
Can Vet J. 2024 Nov;65(11):1189-1193.
2
Complete remission of two canine cases with precursor-targeted immune-mediated anemia after combination therapy with prednisolone, cyclosporine, and oclacitinib.泼尼松龙、环孢素和奥卡西替尼联合治疗后,两例前驱体靶向免疫介导性贫血犬完全缓解。
Open Vet J. 2023 Sep;13(9):1205-1211. doi: 10.5455/OVJ.2023.v13.i9.16. Epub 2023 Sep 30.
3
Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases.
奥卡西替尼治疗犬慢性皮肤红斑狼疮变异型的疗效:七例报告。
Vet Dermatol. 2023 Feb;34(1):53-58. doi: 10.1111/vde.13128. Epub 2022 Oct 13.
4
Shared inflammatory and skin-specific gene signatures reveal common drivers of discoid lupus erythematosus in canines, humans and mice.共享的炎症和皮肤特异性基因特征揭示了犬、人类和小鼠盘状红斑狼疮的共同驱动因素。
Curr Res Immunol. 2021 Mar 31;2:41-51. doi: 10.1016/j.crimmu.2021.03.003. eCollection 2021.
5
Efficacy of oclacitinib for the control of feline atopic skin syndrome: correlating plasma concentrations with clinical response.奥卡西替尼治疗猫特应性皮炎的疗效:与临床反应相关的血浆浓度。
J Feline Med Surg. 2022 Aug;24(8):787-793. doi: 10.1177/1098612X211048458. Epub 2021 Oct 6.